Showing results for "Biotech" in Health & Wellness

Welcome to ”Biotech Talks,” the podcast that delves into the latest innovations and breakthroughs in the biotech industry. Hosted by Zac, an enthusiastic AI/ML researcher, each episode explores cutting-edge technologies, their real-world applications, and the impact they have on transforming healthcare and biotechnology. Whether you’re a biotech professional, a decision-maker, or just curious about the future of biotech, ”Biotech Talks” provides insightful discussions and expert interviews to keep you informed and inspired. Tune in and join us on this exciting journey through the ...

Biotech Banter is hosted by BioCentriq, a highly collaborative CDMO focused exclusively on cell and gene therapy and supporting all stages of process development and clinical manufacturing. This podcast explores the challenges and opportunities of advancing cell and gene therapies to clinic. Hear the perspective of a wide range of contributors ranging from C-level executives to manufacturing operators and more. With expert insights, tips, and information, you'll discover what it takes to set the stage for successful clinical manufacturing, how to decide if working with a CDMO is the right move...

In this series, we discuss how to drive productivity in biotech clinical trials and how to maximize valuation for minimal investment. Historically, R&D productivity has always been an area of focus and priority for the industry, but recent trends are particularly challenging. How do you realize this ultimate goal as protocols are becoming increasingly complex?

Conversaciones sinceras más allá de la oftalmología.

The Base to Base Biotech podcast is a weekly look at what's happening in the world of biotech, with interviews with biotech leaders around the world.Whether it's a new drug, cutting-edge technology, product launches, new technology, major finding announcement or clinical trial results, Base to Base Biotech keeps you informed.The podcast is hosted by former biotech editor and broadcaster, the award-winning media veteran Jim Cornall.Base to Base is an Ayr Coastal Media Ltd production.

Interviews with the researchers, founders, and investors of the BioTech industry. An insiders look into what is going on in the world of BioTech, from curing aging to psychedelic therapy, we interview the game changers of the industry. The unsung hero's that are moving the industry forward in a significant way. The world is going to be a vastly different place in the next 10-20 years because of what's happening in the BioTech industry right now.Human civilization will move forward farther, faster, and more significantly in the next 20 years than it has in all of human history and the Simple ...

A pioneering neuroscientist shows how the long-sought merger of brains with machines is about to become a paradigm-shifting reality. Imagine living in a world where people use their computers, drive their cars, and communicate with one another simply by thinking. In this stunning and inspiring...

Welcome to "The Power of Persistence: From Biotech Incubator to First Product Launch," a three-episode podcast series featuring seasoned experts who share valuable insights and tips about bringing biotech products to market. In this series, we delve into the journey of BioLineRx, a biopharmaceutical company founded in Israel, from its inception as a biotech incubator to achieving FDA approval for its first product, motixafortide.

Encode Ideas authors research on publicly traded micro / small cap healthcare (biotech & medtech) companies. The Plainspoken podcast is an extension of our research, where we will interview executives from micro / small cap health care companies, portfolio managers who invest in micro / small cap healthcare, and key opinion leaders who can offer insights into therapeutics areas of interest to investors. The podcast is for entertainment purposes only and should not be considered financial advice. Our research and disclosures can be found at www.encodelp.com. For our most contemporary commentary...

Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.